Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. / Mattila, Jussi; Soininen, Hilkka; Koikkalainen, Juha; Rueckert, Daniel; Wolz, Robin; Waldemar, Gunhild; Lötjönen, Jyrki.

I: Journal of Alzheimer's Disease, Bind 32, Nr. 4, 2012, s. 969-79.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mattila, J, Soininen, H, Koikkalainen, J, Rueckert, D, Wolz, R, Waldemar, G & Lötjönen, J 2012, 'Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects', Journal of Alzheimer's Disease, bind 32, nr. 4, s. 969-79. https://doi.org/10.3233/JAD-2012-120934

APA

Mattila, J., Soininen, H., Koikkalainen, J., Rueckert, D., Wolz, R., Waldemar, G., & Lötjönen, J. (2012). Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. Journal of Alzheimer's Disease, 32(4), 969-79. https://doi.org/10.3233/JAD-2012-120934

Vancouver

Mattila J, Soininen H, Koikkalainen J, Rueckert D, Wolz R, Waldemar G o.a. Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. Journal of Alzheimer's Disease. 2012;32(4):969-79. https://doi.org/10.3233/JAD-2012-120934

Author

Mattila, Jussi ; Soininen, Hilkka ; Koikkalainen, Juha ; Rueckert, Daniel ; Wolz, Robin ; Waldemar, Gunhild ; Lötjönen, Jyrki. / Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. I: Journal of Alzheimer's Disease. 2012 ; Bind 32, Nr. 4. s. 969-79.

Bibtex

@article{48fa6c281f6b4c559a4a27e0ce038acc,
title = "Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects",
abstract = "In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60-80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6-54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.",
author = "Jussi Mattila and Hilkka Soininen and Juha Koikkalainen and Daniel Rueckert and Robin Wolz and Gunhild Waldemar and Jyrki L{\"o}tj{\"o}nen",
year = "2012",
doi = "10.3233/JAD-2012-120934",
language = "English",
volume = "32",
pages = "969--79",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "I O S Press",
number = "4",

}

RIS

TY - JOUR

T1 - Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects

AU - Mattila, Jussi

AU - Soininen, Hilkka

AU - Koikkalainen, Juha

AU - Rueckert, Daniel

AU - Wolz, Robin

AU - Waldemar, Gunhild

AU - Lötjönen, Jyrki

PY - 2012

Y1 - 2012

N2 - In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60-80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6-54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.

AB - In the diagnostic process of Alzheimer's disease (AD), there may be considerable delays between first contact to outpatient services and a final, definitive diagnosis. In Europe the average delay is 20 months. Nevertheless, patient data preceding clinical AD diagnoses often contains early signs of the disease. Several studies have analyzed data of mild cognitive impairment (MCI) subjects, showing that conversion from MCI to AD can be predicted with a classification accuracy of 60-80%. This accuracy may not be high enough for influencing diagnostic decisions. In this work, the prediction problem is approached differently; a target prediction accuracy is defined first and is then used for identifying MCI patients for whom the required accuracy can be reached. The process uses a novel disease state index method in which patient data are statistically compared to a high number of previously diagnosed cases. It is shown that the disease index values derived from heterogeneous patient data can be used for identifying groups of patients for whom the prediction accuracy reaches the previously set target level. The results also show that 12 months before receiving clinical AD diagnoses, approximately half (51.5%, 95% confidence interval: 48.6-54.2%) of MCI subjects who progressed to AD can be classified with a high accuracy of 87.7%, possibly enough to support earlier diagnostic decisions.

U2 - 10.3233/JAD-2012-120934

DO - 10.3233/JAD-2012-120934

M3 - Journal article

C2 - 22890102

VL - 32

SP - 969

EP - 979

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -

ID: 48606411